This website uses cookies

We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will only use cookies based on your decision.

Key visual

Clinical Guide: Anti-Müllerian Hormone (AMH) Assay 

The Clinical Utility of the AMH Assay

Clinical guide cover

Answering the need for rapid and precise fertility testing solutions.

There is a strong trend in the developed world to delay the decision to have children. This decision is often shifted to the late reproductive years. The delay in having children has increased the incidence of infertility1 and around 17.5% of the adult population (roughly 1 in 6 worldwide) experience infertility issues2. As a result, the use of assisted reproductive technology (ART) by infertile couples is increasing by 5–10% per year.3  Benefits of the AMH assay:

  • Rapid and precise assessment of ovarian reserve and fertility status
  • Simple integration into routine reproductive endocrinology testing workflow on one platform
  • Actionable results from an assay that demonstrates optimal analytical and clinical performance
Complete the form below to access the clinical guide and sign up for our email list around related topics.

To receive the document for free, please fill out the form below. In return, we will provide you the document and further marketing communication. The information you provide below will be processed as described further in the Privacy Notice.

*Required

1
2
3
Subscription Button Icon
Be the first to know about our events, training, and news